JP2022532874A5 - - Google Patents
Info
- Publication number
- JP2022532874A5 JP2022532874A5 JP2021566128A JP2021566128A JP2022532874A5 JP 2022532874 A5 JP2022532874 A5 JP 2022532874A5 JP 2021566128 A JP2021566128 A JP 2021566128A JP 2021566128 A JP2021566128 A JP 2021566128A JP 2022532874 A5 JP2022532874 A5 JP 2022532874A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- tubb4a
- compound
- cells
- leukodystrophy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025065950A JP2025118647A (ja) | 2019-05-09 | 2025-04-12 | 白質ジストロフィーの治療のための組成物および方法、ならびに白質ジストロフィーの治療のための有効な薬剤を同定するための動物全体および細胞モデル |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845637P | 2019-05-09 | 2019-05-09 | |
| US62/845,637 | 2019-05-09 | ||
| US201962924910P | 2019-10-23 | 2019-10-23 | |
| US62/924,910 | 2019-10-23 | ||
| PCT/US2020/032364 WO2020227713A1 (en) | 2019-05-09 | 2020-05-11 | Compositions and methods for the treatment of leukodystrophy and whole animal and cellular models for the identifying efficacious agents for treatment of the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025065950A Division JP2025118647A (ja) | 2019-05-09 | 2025-04-12 | 白質ジストロフィーの治療のための組成物および方法、ならびに白質ジストロフィーの治療のための有効な薬剤を同定するための動物全体および細胞モデル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532874A JP2022532874A (ja) | 2022-07-20 |
| JP2022532874A5 true JP2022532874A5 (cg-RX-API-DMAC7.html) | 2023-05-19 |
Family
ID=73051654
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566128A Pending JP2022532874A (ja) | 2019-05-09 | 2020-05-11 | 白質ジストロフィーの治療のための組成物および方法、ならびに白質ジストロフィーの治療のための有効な薬剤を同定するための動物全体および細胞モデル |
| JP2025065950A Pending JP2025118647A (ja) | 2019-05-09 | 2025-04-12 | 白質ジストロフィーの治療のための組成物および方法、ならびに白質ジストロフィーの治療のための有効な薬剤を同定するための動物全体および細胞モデル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025065950A Pending JP2025118647A (ja) | 2019-05-09 | 2025-04-12 | 白質ジストロフィーの治療のための組成物および方法、ならびに白質ジストロフィーの治療のための有効な薬剤を同定するための動物全体および細胞モデル |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20220265862A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3966336A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022532874A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220007092A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114127300A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020268878A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3139521A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020227713A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021414124A1 (en) * | 2020-12-29 | 2023-07-13 | The Jackson Laboratory | Gait and posture analysis |
| US20240200065A1 (en) * | 2021-04-16 | 2024-06-20 | The Children's Hospital Of Philadelphia | Compositions and methods useful for the treatment of h-abc leukodystrophy |
| CN115992208B (zh) * | 2022-08-03 | 2026-06-26 | 三峡大学 | 一种GLD模型Twitcher小鼠基因型的鉴定引物和鉴定方法 |
| US20250092365A1 (en) * | 2023-09-14 | 2025-03-20 | ReGen Theranostics, Inc. | Method of manufacturing autologous cardiac lineage cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
| CN101914547A (zh) * | 2010-07-28 | 2010-12-15 | 北京华阜康生物科技股份有限公司 | 转人app双突变基因老年痴呆症小鼠模型的建立和应用 |
| EP3249403A4 (en) * | 2015-01-21 | 2019-01-16 | Konica Minolta, Inc. | PHOSPHORAGGREGATNANOPARTICLES FOR FLUORESCENT OBSERVATION |
| EP3286318A2 (en) * | 2015-04-22 | 2018-02-28 | Mina Therapeutics Limited | Sarna compositions and methods of use |
| DK3302522T3 (da) * | 2015-06-02 | 2022-09-26 | Academisch Ziekenhuis Leiden | Midler og fremgangsmåde til behandling af facioscapulohumeral muskeldystrofi (fshd) |
-
2020
- 2020-05-11 US US17/610,050 patent/US20220265862A1/en not_active Abandoned
- 2020-05-11 KR KR1020217039551A patent/KR20220007092A/ko active Pending
- 2020-05-11 JP JP2021566128A patent/JP2022532874A/ja active Pending
- 2020-05-11 WO PCT/US2020/032364 patent/WO2020227713A1/en not_active Ceased
- 2020-05-11 AU AU2020268878A patent/AU2020268878A1/en active Pending
- 2020-05-11 CN CN202080049838.3A patent/CN114127300A/zh active Pending
- 2020-05-11 EP EP20801706.1A patent/EP3966336A4/en active Pending
- 2020-05-11 CA CA3139521A patent/CA3139521A1/en active Pending
-
2025
- 2025-04-12 JP JP2025065950A patent/JP2025118647A/ja active Pending
- 2025-11-17 US US19/391,899 patent/US20260151513A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fiorentini et al. | Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice | |
| JP7591847B2 (ja) | デュシェンヌ型筋ジストロフィーに関連するエクソンスプライシングエンハンサー、sgRNA、遺伝子編集ツールおよび使用 | |
| RU2767201C2 (ru) | Искусственная модификация генома для регуляции экспрессии гена | |
| RS64769B1 (sr) | Varijante adeno-asociranih virusa i postupci upotrebe | |
| Dworkin et al. | Grainyhead-like 3 regulation of endothelin-1 in the pharyngeal endoderm is critical for growth and development of the craniofacial skeleton | |
| KR102138131B1 (ko) | 뇌 종양 동물 모델 및 이의 제조 방법 | |
| JP7338937B2 (ja) | 人工的に操作されたsc機能制御システム | |
| JP2021513866A (ja) | アンジェルマン症候群を処置する方法および組成物 | |
| EP2373301B1 (en) | Methods of diagnosing motor neuron diseases | |
| Lin et al. | RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models | |
| Yang et al. | Loss of Wtap results in cerebellar ataxia and degeneration of Purkinje cells | |
| JP2020500537A (ja) | 機能的ミエリン産生を増進させるための方法および組成物 | |
| CN114286710A (zh) | 治疗亨廷顿病的方法和材料 | |
| JP2025118647A (ja) | 白質ジストロフィーの治療のための組成物および方法、ならびに白質ジストロフィーの治療のための有効な薬剤を同定するための動物全体および細胞モデル | |
| Bol’Shakova et al. | Neuroprotective effect of σ1-receptors on the cell model of Huntington’s disease | |
| US20250040523A1 (en) | Methods and compositions relating to humanized stathmin2 mouse model with disrupted tdp-43 binding sites | |
| JP2024524332A (ja) | アルツハイマー病の治療方法 | |
| KR20240032021A (ko) | 신경 재프로그래밍을 위한 방법 및 조성물 | |
| EP3516052B1 (en) | Recombinant dgkk gene for fragile x syndrome gene therapy | |
| WO2022104011A1 (en) | Methods for the treatment of neurological disorders | |
| WO2021067613A1 (en) | Compositions and methods for treating amyotrophic lateral sclerosis | |
| CN119524136A (zh) | 一种干预apt2靶点的药物的新用途 | |
| WO2023068212A1 (ja) | 神経変性及び筋萎縮モデル動物 | |
| CN121343884A (zh) | 一种circCRIM1在调控软骨细胞分化和软骨稳态中的应用 | |
| CN119614570A (zh) | 抑制Psmd13表达的siRNA及其应用 |